Outcomes of hip fracture surgery during the COVID-19 pandemic

Eur J Orthop Surg Traumatol. 2023 Aug;33(6):2453-2458. doi: 10.1007/s00590-022-03456-z. Epub 2022 Dec 19.

Abstract

Purpose: To investigate if changes to hospital operational models during the COVID-19 pandemic negatively impacted overall time to surgery (TtS) as well as morbidity and mortality rates of hip fractures (HFx).

Methods: 416 patients treated for OTA 31 fractures at a single institution between January 2019 and November 2020 were reviewed. TtS as well as morbidity and mortality rates were obtained from pre-pandemic and pandemic groups.

Results: 263 patients were treated pre-pandemic and 153 were treated during the pandemic. There were no significant differences in median TtS, readmission rates (p = 0.134), reoperation rates (p = 0.052), 30-day (p = 0.095) and 90-day (p = 0.22) mortality rates.

Conclusion: Reallocation of hospital resources in response to the COVID-19 pandemic did not negatively impact surgical timing or complications. TtS for HFx remains a challenge and often requires multidisciplinary care, which is complicated by a pandemic. However, this study demonstrates HFx standard of care can be maintained despite COVID-19 obstacles to treatment efficiency and efficacy.

Keywords: COVID-19; Hip fracture; Morbidity; Mortality; Pandemic; Trauma.

MeSH terms

  • COVID-19* / complications
  • COVID-19* / epidemiology
  • Fracture Fixation, Internal / adverse effects
  • Hip Fractures* / epidemiology
  • Humans
  • Pandemics
  • Reoperation
  • Retrospective Studies